Search research articles
Contact Us
Filters
Showing results (231-240 of 238) with videos related to
Page
of 24
Sort By:
You have reached the last page of results.
This site can display upto 238 results.
Nature
|
July 5, 2023
Therapy-induced APOBEC3A drives evolution of persistent cancer cells
Hideko Isozaki, Ramin Sakhtemani, Ammal Abbasi, et al.
Cancer Discovery
|
May 21, 2017
Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers
Carl U Bialucha, Scott D Collins, Xiao Li, et al.
Cancer Discovery
|
May 30, 2013
Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer
Yan Liu, Kevin Marks, Glenn S Cowley, et al.
Nature
|
July 6, 2017
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S Viswanathan, Matthew J Ryan, Harshil D Dhruv, et al.
Scientific Reports
|
January 15, 2021
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Ye Wang, Morvarid Mohseni, Angelo Grauel, et al.
Nature
|
March 20, 2012
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
Zhao Chen, Katherine Cheng, Zandra Walton, et al.
Cell Chemical Biology
|
March 2, 2023
Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy
Simone Bonazzi, Eva d'Hennezel, Rohan E J Beckwith, et al.
Nature
|
March 31, 2012
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J Garnett, Elena J Edelman, Sonja J Heidorn, et al.
Page
of 24
Search research articles
Search
Showing results (231-240 of 238) with videos related to
Sort By:
Page
of 24
You have reached the last page of results.
This site can display upto 238 results.
Nature
|
July 5, 2023
Therapy-induced APOBEC3A drives evolution of persistent cancer cells
Hideko Isozaki, Ramin Sakhtemani, Ammal Abbasi, et al.
Cancer Discovery
|
May 21, 2017
Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers
Carl U Bialucha, Scott D Collins, Xiao Li, et al.
Cancer Discovery
|
May 30, 2013
Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer
Yan Liu, Kevin Marks, Glenn S Cowley, et al.
Nature
|
July 6, 2017
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S Viswanathan, Matthew J Ryan, Harshil D Dhruv, et al.
Scientific Reports
|
January 15, 2021
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Ye Wang, Morvarid Mohseni, Angelo Grauel, et al.
Nature
|
March 20, 2012
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
Zhao Chen, Katherine Cheng, Zandra Walton, et al.
Cell Chemical Biology
|
March 2, 2023
Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy
Simone Bonazzi, Eva d'Hennezel, Rohan E J Beckwith, et al.
Nature
|
March 31, 2012
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J Garnett, Elena J Edelman, Sonja J Heidorn, et al.
Page
of 24